Edwards Lifesciences (EW) Retained Earnings (2016 - 2025)
Edwards Lifesciences has reported Retained Earnings over the past 17 years, most recently at $14.2 billion for Q4 2025.
- Quarterly results put Retained Earnings at $14.2 billion for Q4 2025, up 5924.34% from a year ago — trailing twelve months through Dec 2025 was $14.2 billion (up 5924.34% YoY), and the annual figure for FY2025 was $14.2 billion, up 5924.34%.
- Retained Earnings for Q4 2025 was $14.2 billion at Edwards Lifesciences, up from -$250.4 million in the prior quarter.
- Over the last five years, Retained Earnings for EW hit a ceiling of $14.2 billion in Q4 2025 and a floor of -$256.0 million in Q3 2022.
- Median Retained Earnings over the past 5 years was $2.6 billion (2021), compared with a mean of $4.1 billion.
- Biggest five-year swings in Retained Earnings: tumbled 104.47% in 2022 and later skyrocketed 5924.34% in 2025.
- Edwards Lifesciences' Retained Earnings stood at $6.1 billion in 2021, then tumbled by 104.2% to -$254.9 million in 2022, then rose by 4.75% to -$242.8 million in 2023, then decreased by 0.7% to -$244.5 million in 2024, then skyrocketed by 5924.34% to $14.2 billion in 2025.
- The last three reported values for Retained Earnings were $14.2 billion (Q4 2025), -$250.4 million (Q3 2025), and $13.9 billion (Q2 2025) per Business Quant data.